首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Multiple myeloma patients at peripheral blood stem cell harvest: restricted usage of TCR beta variable families.
【24h】

Multiple myeloma patients at peripheral blood stem cell harvest: restricted usage of TCR beta variable families.

机译:多发性骨髓瘤患者外周血干细胞收获:TCR beta变量家族的使用受到限制。

获取原文
获取原文并翻译 | 示例
           

摘要

The immune systems of multiple myeloma patients are suppressed by the disease itself, and this immunosuppression is further enhanced by standard therapies. The aim of our study was to evaluate the effects of initial chemotherapy and a peripheral blood mobilisation regimen on T-cell population diversity. Reverse transcription-polymerase chain reaction (RT-PCR) with a new set of primers, in combination with capillary electrophoresis, was established. The methodology was used to analyse the relative expression of 27 T-cell receptor beta variable gene families (BV families) in multiple myeloma patients undergoing peripheral blood stem cell harvest. We found that the overall BV family usage in these patients was restricted; the relative expression of 10 BV families was significantly depressed in patients compared to healthy donors. These findings demonstrate that the preparative regimen for autologous stem cell transplantation affects the T-cell population in terms of the restriction of its T-cell receptor diversity.
机译:多发性骨髓瘤患者的免疫系统受到疾病本身的抑制,而这种免疫抑制则通过标准疗法得到进一步增强。我们研究的目的是评估初始化疗和外周血动员方案对T细胞群体多样性的影响。建立了具有一套新引物的逆转录聚合酶链反应(RT-PCR),并结合了毛细管电泳。该方法用于分析在经历外周血干细胞收获的多发性骨髓瘤患者中27个T细胞受体β可变基因家族(BV家族)的相对表达。我们发现这些患者的总体BV家庭使用受到限制;与健康供体相比,患者中10个BV家族的相对表达显着降低。这些发现证明自体干细胞移植的制备方案就其T细胞受体多样性的限制而言影响T细胞群体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号